Analysis of trametinib medical insurance reimbursement conditions and patients’ actual out-of-pocket expenses

Trametinib (Trametinib) is a MEK1/2 inhibitor, mainly used to treat advanced melanoma and non-small cell lung cancer carrying BRAF V600 mutations. Since its launch in China, trametinib has been included in medical insurance, but medical insurance reimbursement has strict indication restrictions. Only patients who have been confirmed by genetic testing to be positive for BRAF mutations and meet clinical use standards can enjoy medical insurance reimbursement, which also means that some patients may still bear certain out-of-pocket expenses when using it.

In the domestic market, trametinib is available in two specifications: 0.5 mg The latest selling price of 0.5mg×30 tablets is about NT$3,000 to NT$4,000, while 2mg ×30 tablets is between NT$9,000 and NT$12,000. The actual out-of-pocket amount depends on the medical insurance reimbursement ratio and policy differences in the patient's region. Before purchasing drugs, patients should confirm the post-reimbursement price with the local hospital pharmacy or medical insurance department in order to reasonably arrange the drug budget.

For patients who wish to purchase through overseas channels, the international market provides options such as Turkish original version and Laos generic version. The Turkish original drug 2mg×30 tablets sell for about 7,000 to 8,000 yuan, while the price of Laotian generic drugs is only about 1,000 yuan. Although prices are lower, patients need to ensure that the sources are legal and of reliable quality when choosing overseas drugs to avoid affecting efficacy or causing safety issues.

Overall, trametinib is covered by domestic medical insurance, and the financial burden on patients has been significantly reduced, but it is still necessary to reasonably choose the drug version and drug purchase channels based on personal circumstances. Combining doctor's guidance, genetic testing results and medical insurance policies, patients can minimize out-of-pocket expenses while ensuring the curative effect. At the same time, drug storage should meet refrigeration requirements to ensure drug activity and safety.

Reference materials:https://www.drugs.com/